Cell Therapy Incontinence Treatments
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
290
NCT04976153
Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence
Phase: Phase 3
Role: Lead Sponsor
Start: May 11, 2022
Completion: Jul 31, 2027
Loading map...